ARBEL MEDICAL develops innovative, minimally invasive Cryo-therapy products, for the treatment of breast tumors and other internal diseased tissue.     BIOLINERX is a bio- pharmaceutical drug development company that in-licenses compounds primarily from Israeli academia and hospitals and takes these molecules to a higher valuation in future royalty streams by filling the gap in the developmental phase.     CAN-FITE focuses on drugs for treating cancer and inflammatory diseases providing drugs that are highly efficacious in their therapeutic activity but devoid of some of the major shortcomings inherent in many of the drug therapies currently available.     CircuLite focuses on the treatment of advanced heart failure patients who cannot pump enough blood to meet the body’s metabolic needs. The Circulite microvad system’s pump is designed to solve the problems of mechanical failure and blood clotting exhibited in artificial hearts and pumps.     COMPUGEN, a drug and diagnostic discovery company, incorporates ideas and methods from mathematics, computer science and physics into the disciplines of biology, organic chemistry and medicine increasing the success of drug and diagnostic development. Compugen went public on NASDAQ in August 2000.     Intellidx develops devices which provide continuous, accurate, and real-time blood glucose monitoring for clinical use.     Impella is an innovative high-tech enterprise which manufactures and markets intracorporeal micro blood pumps for use in coronary surgery and cardiology. Abiomed acquired Impella for $92 million in May 2005.     Mitralign designs and develops percutaneous transcatheter devices for the treatment of mitral valve regurgitation which is a significant factor in congestive heart failure.     ORIDION is an innovator in the areas of respiratory patient monitoring systems and breath testing analyzers. Oridion went public on the Swiss SWX New Market Exchange in April 2000.     Pathway Medical develops and manufactures an innovative catheter based technology to treat peripheral vascular disease.     PRONEURON focuses on cell therapy and neuroimmunology on the development and commercialization of treatments for spinal cord injuries (SCI) as well as other neurological disorders.     PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing unique technology and knowledge of the ubiquitin system.     TOPSPIN has developed a unique technology for local high-resolution MR imaging using a miniature hand-held probe incorporating all magnetic field sources and eliminating the need for external magnets and a bulky and expensive MRI scanner.     ULTRASPECT develops products for medical imaging based on novel image- processing algorithms.     X TECHNOLOGIES developed a revolutionary balloon angioplasty device designed to address several pressing needs in the coronary angioplasty and stenting market. Acquired by Guidant in March 2003.